Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 5:17pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Nxstage Medical, Inc. (NXTM)
At 5:00AM SGT:
7.81 USD
0.00 (0.00%)
MORE ON NXTM
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
NxStage Medical, Inc.
(NGM:NXTM) Delayed quote data
Last Trade:
7.81 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
7.81
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
9.81
Day's Range:
N/A - N/A
52wk Range:
1.90 - 9.25
Volume:
0
Avg Vol
(3m)
:
95,884.1
Market Cap:
364.70M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-0.96
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
Use Y! Toolbar to track stocks
Add NXTM to Portfolio
Download Data
HEADLINES
NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
PR Newswire
(Wed, Feb 3)
NxStage(R) CEO and Founder to Participate in Innovator's Panel Discussion at the Liquidnet Forum: How the Healthcare Market is Curing Itself
PR Newswire
(Thu, Jan 28)
NxStage Medical, Inc. Earnings Call scheduled for Thu, Feb 25
CCBN
(Tue, Jan 26)
NxStage to Report Fourth Quarter and Full Year 2009 Financial Results
PR Newswire
(Mon, Jan 25)
NxStage to Present at the Deutsche Bank Small and Mid Cap Conference
PR Newswire
(Sat, Jan 23)
NxStage(R) Announces New Vice President and General Manager, International
PR Newswire
(Tue, Jan 19)
Coverage initiated on Nxstage Medical by Rodman & Renshaw
Briefing.com
(Fri, Jan 8)
ObamaCare Using PBMs As A Solution To High Health Care Costs: Which Stocks To Benefit?
Wall Street Transcript
(Thu, Dec 17)
Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
PR Newswire
(Tue, Dec 15)
ThermoGenesis names health care executive to board
AP
(Fri, Dec 11)
More Headlines for NXTM...
ANALYST
EPS Est (next year)
(Dec-09)
:
-0.94
EPS Est (in 2 years)
(Dec-10)
:
-0.65
Avg Rec (current)*:
1.4
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
NxStage Medical, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures in the United States.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices